PMID- 38487144 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240316 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 16 IP - 2 DP - 2024 Feb TI - Adverse Effects of Cancer Treatment in Patients With Cervical Cancer. PG - e54106 LID - 10.7759/cureus.54106 [doi] LID - e54106 AB - BACKGROUND: In lower- to middle-income countries such as India, the literature on the adverse effects (AEs) of cancer treatment in patients with cervical cancer is very limited. This knowledge gap provides an opportunity to investigate and improve the quality of life for women with cervical cancer. OBJECTIVE: The purpose of this study was to assess the AEs of various cancer treatment combinations in patients with cervical cancer. METHODS: This observational, retrospective study analysed 1,030 women with cervical cancer, with a descriptive cross-sectional design, based on a review of medical records from patients who were followed up during the morbidity consultation conducted by a multidisciplinary team of doctors. The AEs of cancer treatment for women with cervical cancer were recorded in these medical records between October 14, 2019, and November 21, 2022, at 10 major public tertiary hospitals in India. RESULTS: This study analysed 1,030 women with cervical cancer aged between 21 and 80 years (mean age: 48.8 +/- 13.9 years; p=0.30). Patients between the ages of 36-50 years reported the most AEs (30.2%; 95% confidence interval (CI): 29.1-32.8) among other age groups. Combined radiation therapy and chemotherapy (CT) was the type of cancer treatment in which there were more AEs, presenting in 56.0% (95% CI: 55-60.1) of patients. Adverse effects associated with the gastrointestinal system were observed in the majority (92.5%, 95% CI: 90.2-96.9) of cervical cancer patients. CONCLUSION: Exposure to different cancer treatments, particularly combination therapy, induces AEs in patients during and after cervical cancer treatment. CI - Copyright (c) 2024, Palagudi et al. FAU - Palagudi, Mahesh AU - Palagudi M AD - Department of General Medicine, P.E.S. Institute of Medical Sciences and Research, Kuppam, IND. FAU - Para, Sneha AU - Para S AD - Department of General Medicine, Maheshwara Medical College and Hospital, Hyderabad, IND. FAU - Golla, Nagasree AU - Golla N AD - Department of General Medicine, I. K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, KGZ. FAU - Meduri, Krishna Chaitanya AU - Meduri KC AD - Department of General Medicine, Maheshwara Medical College and Hospital, Hyderabad, IND. FAU - Duvvuri, Sai Praneeth AU - Duvvuri SP AD - Department of General Medicine, Maheshwara Medical College and Hospital, Hyderabad, IND. FAU - Vityala, Yethindra AU - Vityala Y AD - Department of Research, AJ Research Centre, AJ Institute of Medical Sciences and Research Centre, Mangalore, IND. AD - Department of Pathology, International Higher School of Medicine, International University of Kyrgyzstan, Bishkek, KGZ. FAU - Sajja, Deepika Chowdary AU - Sajja DC AD - Department of General Medicine, Santhiram Medical College, Tirupati, IND. FAU - Damineni, Ujwala AU - Damineni U AD - Department of General Medicine, Maheshwara Medical College and Hospital, Hyderabad, IND. LA - eng PT - Journal Article DEP - 20240213 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC10938271 OTO - NOTNLM OT - adverse effects OT - brachytherapy OT - cervical cancer OT - chemotherapy OT - radiation therapy COIS- The authors have declared that no competing interests exist. EDAT- 2024/03/15 06:44 MHDA- 2024/03/15 06:45 PMCR- 2024/02/13 CRDT- 2024/03/15 04:03 PHST- 2024/02/13 00:00 [accepted] PHST- 2024/03/15 06:45 [medline] PHST- 2024/03/15 06:44 [pubmed] PHST- 2024/03/15 04:03 [entrez] PHST- 2024/02/13 00:00 [pmc-release] AID - 10.7759/cureus.54106 [doi] PST - epublish SO - Cureus. 2024 Feb 13;16(2):e54106. doi: 10.7759/cureus.54106. eCollection 2024 Feb.